Reported 1 day ago
Astera Labs, Inc. (NASDAQ:ALAB), recognized as one of the top IPOs in the last two years, reported a remarkable 150% revenue increase in Q2 2025 compared to the previous year, driven by collaborations with NVIDIA and Alchip Technologies. Following this success, executives have sold significant stock, including CFO Michael Truett Tate's sale of 100,000 shares for over $19 million. Analysts, including Deutsche Bank, have raised the stock’s price target from $160 to $200, reflecting heightened investor interest as the company’s value has surged by over 230% since its IPO.
Source: YAHOO